These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12794859)

  • 41. Synthesis of 7alpha-substituted derivatives of 17beta-estradiol.
    Jiang XR; Sowell JW; Zhu BT
    Steroids; 2006 May; 71(5):334-42. PubMed ID: 16563449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
    Seeger H; Huober J; Wallwiener D; Mueck AO
    Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.
    Swamy N; Purohit A; Fernandez-Gacio A; Jones GB; Ray R
    J Cell Biochem; 2006 Oct; 99(3):966-77. PubMed ID: 16741968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens.
    Coradini D; Pellizzaro C; Speranza A; Daidone MG
    Cell Mol Life Sci; 2004 Jan; 61(1):76-82. PubMed ID: 14704855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and bioactivities of steroid-linked taxol analogues as potential targeted drugs for prostate and breast cancer.
    Liu C; Strobl JS; Bane S; Schilling JK; McCracken M; Chatterjee SK; Rahim-Bata R; Kingston DG
    J Nat Prod; 2004 Feb; 67(2):152-9. PubMed ID: 14987051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
    Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
    J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of 17beta-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines.
    Provencher-Mandeville J; Descôteaux C; Mandal SK; Leblanc V; Asselin E; Bérubé G
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2282-7. PubMed ID: 18356047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of 17α-(dimethylphenyl)vinyl estradiols as probes of the estrogen receptor-α ligand binding domain.
    Hanson RN; McCaskill E; Tongcharoensirikul P; Dilis R; Labaree D; Hochberg RB
    Steroids; 2012 Apr; 77(5):471-6. PubMed ID: 22273809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells.
    Utsumi T; Leese MP; Chander SK; Gaukroger K; Purohit A; Newman SP; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):219-27. PubMed ID: 15862969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C6-(N,N-butyl-methyl-heptanamide) derivatives of estrone and estradiol as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: Chemical synthesis and biological evaluation.
    Cadot C; Laplante Y; Kamal F; Luu-The V; Poirier D
    Bioorg Med Chem; 2007 Jan; 15(2):714-26. PubMed ID: 17110114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
    Leese MP; Hejaz HA; Mahon MF; Newman SP; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2005 Aug; 48(16):5243-56. PubMed ID: 16078843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
    Chang SB; Miron P; Miron A; Iglehart JD
    J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor.
    van der Woude H; Ter Veld MG; Jacobs N; van der Saag PT; Murk AJ; Rietjens IM
    Mol Nutr Food Res; 2005 Aug; 49(8):763-71. PubMed ID: 15937998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of type 2 17beta-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure-activity relationships.
    Bydal P; Auger S; Poirier D
    Steroids; 2004 May; 69(5):325-42. PubMed ID: 15219411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
    Zheng ZY; Zheng SM; Bay BH; Aw SE; C-L Lin V
    Breast Cancer Res Treat; 2008 Jul; 110(1):111-25. PubMed ID: 17687644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
    Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of triphenylacrylonitrile derivatives on estradiol-receptor binding and on human breast cancer cell growth.
    Bignon E; Pons M; Crastes de Paulet AC; Doré JC; Gilbert J; Abecassis J; Miquel JF; Ojasoo T; Raynaud JP
    J Med Chem; 1989 Sep; 32(9):2092-103. PubMed ID: 2769681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.